logo
Select company
Select metric
23.49%Debt to Assets Ratio
VS
Market
48
Sector
37
Industry
26
History
5
$ 10.01Close
$ 9.41 - $ 18.35 52-Week Range
Ticker Information

Ticker

SPRY

Company Name

ARS PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARS PHARMACEUTICALS INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SPRY - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 313.47M$ 73.62M23.49%
3/31/2025$ 327.32M$ 69.46M21.22%
12/31/2024$ 351.15M$ 69.42M19.77%
9/30/2024$ 217.6M$ 102K0.05%
6/30/2024$ 221.97M$ 160K0.07%
3/31/2024$ 227.58M$ 217K0.1%
12/31/2023$ 233.19M$ 274K0.12%
9/30/2023$ 248.56M$ 327K0.13%
6/30/2023$ 258.75M$ 379K0.15%
3/31/2023$ 271.19M$ 431K0.16%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARS PHARMACEUTICALS INC's latest trailing twelve months (TTM) Debt to Assets stands at 99.83%.
  • Over the past 5 years, ARS PHARMACEUTICALS INC's average Debt to Assets has been 8.48%.
  • The median Debt to Assets for ARS PHARMACEUTICALS INC during this period was 0.91%
  • ARS PHARMACEUTICALS INC reached its highest Debt to Assets over the past 5 years at 99.83%.
  • The lowest Debt to Assets recorded by ARS PHARMACEUTICALS INC in the same timeframe 0.05%

ARS PHARMACEUTICALS INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
WVE : WAVE LIFE SCIENCES LTD 8.6%ZYME : ZYMEWORKS INC 4.57%NAGE : NIAGEN BIOSCIENCE INC 3.6%CRMD : CORMEDIX INC 0.17%PHAT : PHATHOM PHARMACEUTICALS INC 220.99%URGN : UROGEN PHARMA LTD 60.33%GYRE : GYRE THERAPEUTICS INC 0.91%BEAM : BEAM THERAPEUTICS INC 11.13%ANAB : ANAPTYSBIO INC 103.34%NRIX : NURIX THERAPEUTICS INC 10.81%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for ARS PHARMACEUTICALS INC is calculated as follows: Debt [ $ 15.62M ] / Assets [ $ 15.65M ]
(=) Debt to Assets [ 99.83% ]

SPRY - Debt to Assets Ratio, Last 5 years

0.05%

Minimum

Sep 30, 2024

99.83%

Maximum

Dec 31, 2019

8.48%

Average

0.91%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.51%